Real world effectiveness of sotrovimab in preventing COVID-19–related hospitalisation or death in patients infected with Omicron BA.2-Reference-Cited by-同舟云学术

Real world effectiveness of sotrovimab in preventing COVID-19–related hospitalisation or death in patients infected with Omicron BA.2

Published:2024-02 Issue:2 Volume:17 Page:315-320
ISSN:1876-0341
Container-title:Journal of Infection and Public Health
language:en
Short-container-title:Journal of Infection and Public Health

Author:

Behzad Alwaleed^ORCID,Mohamed Aamal,Ali Ahmed,Niinuma Sara,Butler Alexandra E.,Alqahtani Manaf^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Reference22 articles.

1. Tracking sars-COV-2 variants [Internet]. World Health Organization. World Health Organization; [cited 21 Nov2022]. Available from: https://www.who.int/activities/tracking-SARS-CoV-2-variants/.

2. SARS-COV-2 variant evasion of monoclonal antibodies based on in vitro studies;Cox;Nat Rev Microbiol,2022

3. Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab;Gupta;N Engl J Med,2021

4. Evolution of the sars‐cov‐2 omicron variants BA.1 to Ba.5: Implications for immune escape and transmission;Shrestha;Rev Med Virol,2022

5. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2;Kawaoka;Res Sq,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?;Journal of Infection and Public Health;2024-09

2. SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines;Science Immunology;2024-08-09

3. Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID‐19: A systematic review and meta‐analysis;Immunity, Inflammation and Disease;2024-04